Document Type



Media is loading

Publication Date



I am currently the medical director of a 25 bed state of the art MICU at Thomas Jefferson University Hospital. I have held the position since finishing my fellowship in 2002. My areas of interest are mechanical ventilation, ARDS, sepsis, education, and quality improvement. My current academic and QI time involve these areas.

Specifically, we are working on improving ways to implement evidence based practice for mechanical ventilation in ARDS including education and physician order entry protocols. I am also working in a inter-divisional multidisciplinary fashion in updating hospital protocols for mechanical ventilation liberation, ARDS, and alternate modes of ventilation in respiratory failure.

I am also involved in developing and instituting a multi-hospital initiative to improve sepsis outcomes through the use of early identification systems, guidelines, protocols, and education. I work with physicians in critical care, infectious diseases, neuro-critical care, and trauma-critical care as well as pharmacy, nursing, and hospital administration to implement the initiative.

In addition, I am working on ARDS-specific projects looking at risk factors for failure of conventional ventilation, use of integrative indices to predict failure of conventional ventilation, and use of ECMO in ARDS in collaboration with cardiothoracic surgery-critical care.

Finally, I am working on a GI bleed pathway with the department of gastroenterology, emergency medicine, interventional radiology, blood bank, and surgery.

In short, my interest in mechanical ventilation, ARDS, and sepsis, experience as medical director of the MICU, and prior collaboration with multiple departments and disciplines at Jefferson would help in this ARDS study.



1. Describe modifiable and non-modifiable risk factors for acute respiratory distress syndrome (ARDS).

2. Describe methods of identifying patients at risk for acute respiratory distress syndrome (ARDS).

3. Describe how early identification of patients at risk may in the future affect clinical management as well as clinical research options.